Stockscreener 앱 받기
4.37
4.59%
-0.21
시간 외 거래:
4.36
-0.010
-0.23%
Evoke Pharma Inc 주식(EVOK)의 최신 뉴스
EVOK (Evoke Pharma) Total Assets : $14.15 Mil (As of Sep. 2024) - GuruFocus.com
Diabetic Gastroparesis Treatment Market: Global Size, Share, - openPR
Altium Capital Management LP Increases Stake in Evoke Pharma Inc - GuruFocus.com
Canopy Growth (CGC) Stock Dives Amid Financial Struggles and Ind - GuruFocus.com
CRON Experiences Significant Stock Dip Amid Market Volatility - GuruFocus.com
Nasal Drug Delivery Technology Market Breakthrough in Patient Care, Projected Market Growth to USD 7.8 Billion by 2031Market Research Intellect - The Malaysian Reserve
By popular demand: SiGMA Europe launches fourth shed - GlobeNewswire Inc.
Evoke Pharma (NASDAQ:EVOK) Coverage Initiated by Analysts at StockNews.com - Defense World
Evoke Pharma Third Quarter 2024 Earnings: Misses Expectations - Yahoo Finance
Evoke Pharma earnings missed by $0.95, revenue fell short of estimates - Investing.com UK
(EVOK) Trading Advice - Stock Traders Daily
Evoke Pharma Reports Q3 2024 Financial Results - TipRanks
Canopy Growth (CGC) Stock Surges 5.2% Amid Industry Movement - GuruFocus.com
Evoke Pharma, Inc. Reports Third Quarter 2024 Financial Results - The Manila Times
BlackLine Announces the Planned Retirement of Chief Financial Officer and Names Successor - The Manila Times
Nantahala Capital Management's Strategic Acquisition in Evoke Ph - GuruFocus.com
Ironwood Pharmaceuticals (IRWD) Sees Stock Surge Amid Positive A - GuruFocus.com
Gastroparesis Drugs Market to Grow by USD 1.42 Billion from 2024-2028, Driven by Rising Diabetes Rates and AI-Driven Market Trend InsightsTechnavio - The Malaysian Reserve
Is Abbott Laboratories (ABT) the Best Pharma Stock to Buy Right Now? - Yahoo Canada Finance
Evoke Pharma, Inc.'s (NASDAQ:EVOK) Shift From Loss To Profit - Yahoo Finance
Evoke Pharma (NASDAQ:EVOK) Earns Sell Rating from Analysts at StockNews.com - Defense World
Global Digestive Health Market Size, Share And Growth Analysis For 2024-2033 - EIN News
Canopy Growth Corporation (CGC) Stock Price, News, Quote & History - Yahoo Finance
Evoke Pharma (FRA:EV0) Enterprise Value : €1.02 Mil (As of Nov. 01, 2024) - GuruFocus.com
Gastroparesis Treatment Market Top Trends and Growth Analysis: - openPR
When Will Evoke Pharma, Inc. (NASDAQ:EVOK) Become Profitable? - Simply Wall St
Why VF Corp Shares Are Trading Higher By Around 21%; Here Are 20 Stocks Moving Premarket - Benzinga
Five things for pharma marketers to know for Tuesday morning - MM+M Online
Evoke Pharma holds Buy rating with $18 target from Laidlaw - Investing.com
S&P 500 Moves Higher; Philips Shares Plunge After Q3 EarningsKoninklijke Philips (NYSE:PHG) - Benzinga
Monte Rosa Therapeutics, Evoke Pharma, and Autonomix Medical: The Top 3 Stocks Capturing Retail Attention - Barchart
Evoke Pharma Shares Soar on Positive Data for Gimoti Nasal Treatment in Diabetic Gastroparesis - Yahoo Finance
What made Evoke Pharma stock more than double on Monday? - Invezz
Crude Oil Tumbles Over 5%; Autonomix Medical Shares Spike Higher - Benzinga
Evoke Pharma Shares Rise 70% on Gimoti Data in GLP-1 Users - MarketWatch
Evoke stock rockets 90% on study of Gimoti in GLP-1 users (NASDAQ:EVOK) - Seeking Alpha
Dow Jumps Over 300 Points; ON Semiconductor Earnings Top ViewsHealthcare Triangle (NASDAQ:HCTI) - Benzinga
Pre-market Movers: EVOK, HCTI, GLUE, MNPR... - RTTNews
Evoke Pharma Stock Is Soaring Monday: What's Going On? - Benzinga
Evoke Pharma reports significant benefits of GIMOTI in DGP study - Investing.com India
Evoke Pharma & EVERSANA Announce Statistically Significant - GlobeNewswire
Evoke Pharma & EVERSANA Announce Statistically Significant Improvement in Patient Outcomes for GLP-1 users with Diabetic Gastroparesis using GIMOTI® - StockTitan
Gastroparesis Drugs Market: Size, Share, Trends, and Forecast for 2024-2033 - openPR
Global Manufacturer and Distributor Chooses Bridgeline's AI-Powered HawkSearch - The Manila Times
Evoke Pharma to Showcase Award-Winning Research at the 2024 American College of Gastroenterology Annual Scientific Meeting - The Manila Times
Evoke Pharma to Showcase Award-Winning Research at the 2024 - GlobeNewswire
Evoke Pharma appoints Benjamin Smeal as new director By Investing.com - Investing.com Canada
Evoke Pharma appoints Benjamin Smeal as new director - Investing.com India
Evoke Pharma Appoints Benjamin Smeal as Director - TipRanks
Evoke Pharma, Inc. Appoints Benjamin Smeal to Serve as Class II Director - Marketscreener.com
Evoke Pharma appoints new board member Ben Smeal - Investing.com India
0.79%
0.15%
자본화:
|
볼륨(24시간):